Artes Medical, which is a medical technology firm developing injectable aesthetic products for the dermatology and plastic surgery markets, filed for an IPO with the SEC on Friday. The company has several products in development but has yet to generate sales. Cowen & Co. and Lazard Capital Markets are the joint book runners on the deal. The company has filed to be traded under the ticker ARTE on the NASDAQ. Pricing terms were not disclosed in the initial filing.
